Andrea GARDINI

Chief Surgeon

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Andrea Gardini is the Chief Surgeon at Presidio Ospedaliero G e C Mazzoni in Italy. His research focuses on minimally invasive pancreatic resections, the management of pancreatic neuroendocrine neoplasms, and the impacts of neoadjuvant therapy in pancreatic cancer. He has contributed significantly to prospective studies and clinical reviews on advanced surgical techniques and treatment protocols for pancreatic disease.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Fabio Giannone

INSERM U1111

FRANCE

View details

Sara Massironi

ITALY

View details

Davide Citterio

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Cristina Ridolfi

Professor Adjunct

Humanitas University

ITALY

View details

Iztok Hozo

Indiana University Northwest

UNITED STATES

View details

Wooil Kwon

Associate Professor

Seoul National University Hospital

SOUTH KOREA

View details

Massimo Falconi

Full Professor of Surgery

Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia

ITALY

View details

Alessandro Esposito

Professore a Contratto

University of Verona

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrea GARDINI

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022

Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer

Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial

Neoadjuvant therapy in pancreatic ductal adenocarcinoma: A competing risk analysis

First 100 minimally invasive liver resections in a new tertiary referral centre for liver surgery

First 100 minimally invasive liver resections in a new tertiary referral centre for liver surgery

The Oncologic Impact of Pancreatic Fistula After Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma of the Body and the Tail: A Multicenter Retrospective Cohort Analysis

Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study.

Benchmarking a new tertiary referral center for hepato-biliary surgery through a critical systematic review of available literature

Erratum to: Chemoradiotherapy (gemox plus helical tomotherapy) for unresectable locally advanced pancreatic cancer: A phase II study (Cancers, (2019), 11)

Collaborators (8)

Fabio Giannone

Sara Massironi

Davide Citterio

Cristina Ridolfi

Iztok Hozo

Wooil Kwon

Massimo Falconi

Alessandro Esposito

Make your next move.